Not much is known about their side effects in older people
In the SURMOUNT-1 trial, adults without diabetes on tirzepatide lost an average of 15-22% of body weight over 72 weeks, depending on dose
Cardiovascular safety of stimulants in adult ADHD: a clinical review
Pharmacological characterization of apraglutide, a novel long-acting peptidic glucagon-like peptide-2 agonist, for the treatment of short bowel syndrome
In this article, well explore how retatrutide and related GLP-1 medications affect lipids, with a special focus on the glucagon receptor pathway that may explain their LDL-lowering effect
Activation of Longevity Proteins: NAD+ is an essential "fuel" for sirtuins (a class of proteins associated with longevity and anti-aging), activating these proteins and regulating cellular aging, inflammation, and metabolism